OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study - CORRIGENDUM

Can J Neurol Sci. 2024 Jan;51(1):149. doi: 10.1017/cjn.2023.317. Epub 2023 Dec 18.
No abstract available

MeSH terms

  • Botulinum Toxins, Type A* / therapeutic use
  • Chronic Disease
  • Humans
  • Migraine Disorders* / drug therapy
  • Quality of Life
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A